Jayagopal Ashwath
SEC CIK 2008983 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | Chief Scientific, Dev. Ofc | 509.2K | $6,195 | $58.2K | 8 | 2024-02-12 | 2026-04-23 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 16:26 | 2026-04-23 | IRD | Opus Genetics, Inc. | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | S - Sale | $5.19 | -7,542 | 509.2K | -1% | -$39.2K | |
| 2026-03-18 | 2026-03-16 | IRD | Opus Genetics, Inc. | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | S - Sale | $5.12 | -3,719 | 516.8K | -0.7% | -$19.0K | |
| 2026-02-17 | 2026-02-12 | IRD | Opus Genetics, Inc. | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | F - Tax | $3.39 | -5,313 | 520.5K | -1% | -$18.0K | |
| 2026-01-26 | 2026-01-22 | IRD | Opus Genetics, Inc. | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | A - Grant | $0.00 | +400.0K | 525.8K | +318% | $0 | |
| D | 2025-03-17 | 2025-03-13 | IRD | Opus Genetics, Inc. | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | A - Grant | $0.00 | +52.5K | 125.8K | +72% | $0 |
| 2025-02-18 | 2025-02-13 | IRD | Opus Genetics, Inc. | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | F - Tax | $1.15 | -5,193 | 73.3K | -7% | -$5,972 | |
| 2024-05-24 | 2024-05-22 | IRD | Opus Genetics, Inc. | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | P - Purchase | $1.77 | +3,500 | 78.5K | +5% | +$6,195 | |
| D | 2024-02-14 | 2024-02-12 | IRD | Opus Genetics, Inc. | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations